• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 19191
Device Problem Material Twisted/Bent (2981)
Patient Problems Hyperglycemia (1905); Nausea (1970); Vomiting (2144); No Code Available (3191)
Event Date 10/20/2020
Event Type  Injury  
Manufacturer Narrative
The device has not been returned/received to date.If the device is received, a supplemental report will be submitted with the investigation results.We are unable to determine if any product condition could have contributed to the reported hospitalization, bent/kinked cannula and diabetic ketoacidosis.Lot release records were reviewed and the product lot met all acceptance criteria.
 
Event Description
It was reported that a patient went to the hospital and was diagnosed with diabetic ketoacidosis (dka).The patient's blood glucose values reached 388 mg/dl.For treatment, the patient stated that she was given phenergan for nausea, three (3) bags of intravenous (iv) saline, iv insulin, two (2) bags of iv calcium and a heparin shot, while in the hospital's intensive care unit.The patient had flu like symptoms, body aches and was vomiting.The ketones were very high.The patient wore the pod between 4 and 24 hours on the hips/buttocks.The cannula was bent/kinked.The patient was discharged on (b)(6)2020 after 1 day.
 
Manufacturer Narrative
The exposed portion of the soft cannula was observed to bent.During the investigation, the bend did not prevent fluid from exiting the distal tip of the soft cannula and no signs of leakage were observed.The data downloaded from the device did not show any signs of struggle during the run.No other damages or defects were found with the device.Although the cannula was damaged, the timing and cause of the damage is unknown.No blood was observed on or within the device.The cannula assembly and bottom housing were inspected for manufacturing deficiencies that could cause bleeding or bruising and no issues were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
MDR Report Key10802248
MDR Text Key215082993
Report Number3004464228-2020-17362
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385081120033
UDI-Public(01)20385081120033(11)200530(17)211130(10)L45825
Combination Product (y/n)N
PMA/PMN Number
K192659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 10/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/30/2021
Device Model Number19191
Device Catalogue NumberZXP425
Device Lot NumberL45825
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/18/2020
Date Manufacturer Received12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age64 YR
-
-